Patel, 58 patient various antiandrogen prophylaxis study: 55% lower mortality [p=0.22], 69% lower ventilation [p=0.19], and 77% lower hospitalization [p=0.02] https://c19p.org/patel3
copied to clipboard
Does androgen deprivation therapy protect against severe complications from COVID-19?
et al., Annals of Oncology, doi:10.1016/j.annonc.2020.06.023
Retrospective 58 prostate cancer patients in the USA, showing lower risk of hospitalization with ADT.
|
risk of death, 55.2% lower, RR 0.45, p = 0.22, treatment 4 of 22 (18.2%), control 10 of 36 (27.8%), adjusted per study, odds ratio converted to relative risk, multivariable.
|
|
risk of mechanical ventilation, 69.0% lower, OR 0.31, p = 0.19, treatment 22, control 36, adjusted per study, multivariable, RR approximated with OR.
|
|
risk of hospitalization, 77.0% lower, OR 0.23, p = 0.02, treatment 22, control 36, adjusted per study, multivariable, RR approximated with OR.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
Patel et al., 7/9/2020, retrospective, USA, North America, peer-reviewed, 7 authors, study period 1 March, 2020 - 4 June, 2020.
Please send us corrections, updates, or comments. Vaccines and
treatments are both valuable and complementary. All practical, effective, and
safe means should be used. No treatment, vaccine, or intervention is 100%
available and effective for all current and future variants. Denying the
efficacy of any method increases mortality, morbidity, collateral damage, and
the risk of endemic status. We do not provide medical advice. Before taking
any medication, consult a qualified physician who can provide personalized
advice and details of risks and benefits based on your medical history and
situation. FLCCC and WCH
provide treatment protocols.